Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02486003 · ClinicalTrials.gov registry record

Testing mTBI in Athletes

A clinical trial, sponsored by University of Miami.

Completed
Registry status
329
Enrollment target

NCT02486003: Completed study, sponsored by University of Miami.

NCT02486003 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 329 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02486003 has completed, sponsored by University of Miami.

COMPLETED
Registry status
329 participants
Enrollment target

Study Summary

This study will assess the effectiveness of a portable goggle system in the diagnosis of mild traumatic brain injury (mTBI) in athletes.

Primary Outcome

IPAS testing will be conducted by placing the IPAS goggles on the head of a patient and asking the patient to follow instructions while a set of tests is performed. Each of these tests simply involves eye motions in response to a target.

Trial Details

FieldValue
Enrollment Target 329 participants
Start Date 2015-05
Est. Completion 2017-08-14
University of Miami

721 total trials

What the finished NCT02486003 record still lists

NCT02486003 is an observational study that tracks outcomes without assigning an intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02486003 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02486003 about?

NCT02486003 is a clinical study titled "Testing mTBI in Athletes". This study will assess the effectiveness of a portable goggle system in the diagnosis of mild traumatic brain injury (mTBI) in athletes.

What is the current status of trial NCT02486003?

This trial is currently completed. The enrollment target is 329 participants. The study started on 2015-05. Estimated completion is 2017-08-14.

Who is sponsoring clinical trial NCT02486003?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06036446 · 329 participants · NA

    LATe Cerclage in High-risk Pregnancies (LATCH)

  • NCT00359684 · 330 participants

    Use of Cysteamine in the Treatment of Cystinosis

  • NCT03817502 · 330 participants · Phase 3

    Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  • NCT03922724 · 330 participants · Phase 2

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02486003, the US trial registry maintained by the National Library of Medicine. NCT02486003 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.